| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/15/2012 | EP2418191A1 Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same |
| 02/15/2012 | EP2417446A1 A method of characterizing phytochemicals from trigonella foenum graceum |
| 02/15/2012 | EP2417135A1 Substituted triazolopyridines and analogs thereof |
| 02/15/2012 | EP2417121A1 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| 02/15/2012 | EP2417107A1 Crystal forms of saxagliptin |
| 02/15/2012 | EP2416797A2 Amylin agonist compounds for estrogen-deficient mammals |
| 02/15/2012 | EP2416793A1 A plant extract comprising statins and preparation techniques and uses thereof |
| 02/15/2012 | EP2416786A1 Phosphate-binding magnesium salts and uses thereof |
| 02/15/2012 | EP2416776A2 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 02/15/2012 | EP2416771A2 Methods and compositions of pi-3 kinase inhibitors for treating fibrosis |
| 02/15/2012 | EP2416656A1 Methods for preventing and/or treating lysosomal storage disorders |
| 02/15/2012 | EP2073806B1 Use of spiro-oxindole compounds as therapeutic agents |
| 02/15/2012 | EP1735268B1 Opioid receptor antagonists |
| 02/15/2012 | EP1572227B1 Pik4cb involved in the regulation of energy homeostasis |
| 02/15/2012 | EP1532446B1 G-protein coupled receptor ligands and methods |
| 02/15/2012 | EP1532161B1 Vectors for expression of hml-2 polypeptides |
| 02/15/2012 | EP1196430B1 Purification and stabilization of peptide and protein pharmaceutical agents |
| 02/15/2012 | CN102356068A 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds |
| 02/15/2012 | CN102356065A Piperidine derivatives as nk3 receptor antagonists |
| 02/15/2012 | CN102355911A Use of vgii3 activity modulator for the modulation of adipogenesis |
| 02/15/2012 | CN102355898A Agent for promoting energy consumption |
| 02/15/2012 | CN102355897A Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug |
| 02/15/2012 | CN102355896A Composition and method for treatment of diabetes |
| 02/15/2012 | CN102351959A Preparation method and application of multiflower knotweed vine polysaccharide chelate zinc |
| 02/15/2012 | CN102351918A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 02/15/2012 | CN102351880A Cyanoaminoquinolones and tetrazoloaminoquinolones as GSK-3 inhibitors |
| 02/15/2012 | CN102351776A Fluvastatin sodium compound and preparation method thereof |
| 02/15/2012 | CN102351771A Atorvastatin calcium compound with high bioavailability |
| 02/15/2012 | CN102351732A Nuclear receptor binding agents |
| 02/15/2012 | CN102351678A Process for the preparation of a granular microbial biomass and isolation of valuable compounds therefrom |
| 02/15/2012 | CN102349937A Preparation method of ixeris sonchifolia hance extractive |
| 02/15/2012 | CN102349920A Sulfanilamide medicament composition for wound surface |
| 02/15/2012 | CN102349909A Pharmaceutical composition for lowering blood lipid |
| 02/15/2012 | CN102349906A Atorvastatin calcium and nicotinic acid composition and preparation method thereof |
| 02/15/2012 | CN102349905A Melbine crystal, medicinal composition of melbine crystal and pioglitazone and preparation method for medicinal composition |
| 02/15/2012 | CN102349881A Levocarnitine thin film coated tablets and preparation method thereof |
| 02/15/2012 | CN101978954B 壳聚糖微粒的制备及应用 Preparation and application of chitosan microparticles |
| 02/15/2012 | CN101966294B 一种外用减肥中药 A topical medicine to lose weight |
| 02/15/2012 | CN101904829B 药物渗透泵制剂 Pharmaceutical preparations osmotic pump |
| 02/15/2012 | CN101810778B Chinese medicinal composition for treating diabetes and preparation method thereof |
| 02/15/2012 | CN101810585B 一种转化糖(果糖/葡萄糖)药物组合物微球注射剂 A transformed sugar (fructose / glucose) pharmaceutical compositions microsphere injection |
| 02/15/2012 | CN101732698B 一种具有降血糖功效的中药制剂及其制备方法与应用 Chinese medicine and its preparation method and application having a hypoglycemic effect of |
| 02/15/2012 | CN101683108B 一种生姜和金银花复合口味软冰淇淋浆料的制备方法 Method for preparing a composite ginger and honeysuckle flavors of soft ice cream slurry |
| 02/15/2012 | CN101663282B 包含β-氨基的DPP-Ⅳ抑制剂及其制备方法以及用于预防和治疗糖尿病或肥胖症的含有所述抑制剂的药物组合物 DPP-Ⅳ inhibitors and their preparation method comprising β- amino group and a pharmaceutical composition for the prevention and treatment of diabetes or obesity comprising the inhibitor |
| 02/15/2012 | CN101560454B 一种黑米健身酒及其酿造方法 One kind of black rice wine and brewing method Fitness |
| 02/15/2012 | CN101516402B 凝胶状经肠营养剂 Gel-type enteral nutrient |
| 02/15/2012 | CN101415429B 脂肪蓄积抑制剂 Fat accumulation inhibitor |
| 02/15/2012 | CN101310751B 一种具有益气养血作用的药物组合物的检测方法 BNI detection method has the effect of a pharmaceutical composition |
| 02/15/2012 | CN101085743B 含氟烷氧基康普立停衍生物及制法和用途 Fluoroalkyloxy Kang Puli parked containing derivatives and preparation method and uses |
| 02/14/2012 | US8115027 NPY Y5 antagonist |
| 02/14/2012 | US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/14/2012 | US8114958 Therapy for metabolism disorders; obesity; diabetes; cardovascular disordrs; eating disorders; hypoglycemic agents; hypotensive agents; dyslipidemia; sleep disorders; respiraotry system disorders; osteoarthritis; insulin resistance |
| 02/14/2012 | US8114911 Prostaglandin compounds for the treatment of obesity |
| 02/14/2012 | US8114880 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds |
| 02/14/2012 | US8114837 Method for inhibiting postprandial rise in blood glucose by administering κ-casein |
| 02/14/2012 | CA2463154C Heterocyclic compounds and methods of use |
| 02/09/2012 | WO2012019188A2 Methods and compositions for the inhibition of fructokinase |
| 02/09/2012 | WO2012019168A2 Engineered nucleic acids and methods of use thereof |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018127A1 Islets of langerhans transplant using islets of langerhans and adipose tissue derived stem cells |
| 02/09/2012 | WO2012018059A1 Heterocyclic compound |
| 02/09/2012 | WO2012018058A1 Fused heterocyclic ring compound |
| 02/09/2012 | WO2012017551A1 Therapeutic agent for disease |
| 02/09/2012 | WO2012017451A1 A bio-stabilized resveratrol formulation |
| 02/09/2012 | WO2012017363A1 Effervescent solid galenic forms for animals |
| 02/09/2012 | WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 02/09/2012 | WO2012017088A1 Use of inhibitors of porphobilinogen deaminase in the treatment of congenital erythropoietic porphyria |
| 02/09/2012 | WO2012017029A1 Novel salts of saxagrliptin with organic di-acids |
| 02/09/2012 | WO2012017028A1 A novel crystalline compound comprising saxagliptin and phosphoric acid |
| 02/09/2012 | WO2012016487A1 Ptp1b inhibitors, synthesis thereof and application thereof in preparation of medicaments for treating type 2 diabetes mellitus |
| 02/09/2012 | WO2012016419A1 Glp-1 derivatives and uses thereof |
| 02/09/2012 | WO2011153430A3 Inhibiting striated muscle activator of rho signaling (stars) to improve glycemic control |
| 02/09/2012 | US20120035274 Composition for Prevention or Treatment of Obesity, Dyslipidemia, Fatty Liver or Insulin Resistance Syndrome Comprising Camphene as Active Ingredients |
| 02/09/2012 | US20120035263 Condiment |
| 02/09/2012 | US20120035262 Compositions and methods for lowering triglycerides |
| 02/09/2012 | US20120035261 Deuterium-enriched saxagliptin |
| 02/09/2012 | US20120035257 Histone Deacetylase Inhibitors |
| 02/09/2012 | US20120035251 Thiophene inhibitors of ikk-b serine-threonine protein kinase |
| 02/09/2012 | US20120035249 Targeted Mucosal Treatment of Obesity and Diabetes |
| 02/09/2012 | US20120035242 Pharmaceutical composition for treating obesity or diabetes |
| 02/09/2012 | US20120035241 Use of inhibitors of plac8 activity for the modulation of adipogenesis |
| 02/09/2012 | US20120035234 Composition comprising free amino acids |
| 02/09/2012 | US20120035225 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics |
| 02/09/2012 | US20120035222 Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine |
| 02/09/2012 | US20120035213 Quinoline derivative |
| 02/09/2012 | US20120035208 Pyrazolopyridine pi3k inhibitor compounds and methods of use |
| 02/09/2012 | US20120035204 Methods for Treating Obesity and Disorders Associated with Hyperlipidemia in a Mammal |
| 02/09/2012 | US20120035196 Carboxylic acid compound |
| 02/09/2012 | US20120035195 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 02/09/2012 | US20120035194 Substituted 2-amino-fused heterocyclic compounds |
| 02/09/2012 | US20120035191 Deuterium-enriched pyrimidine compounds and derivatives |
| 02/09/2012 | US20120035189 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 02/09/2012 | US20120035187 Anti-neurodegenerative disease agent |
| 02/09/2012 | US20120035179 Modulators of atp-binding cassette transporters |
| 02/09/2012 | US20120035178 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 02/09/2012 | US20120035172 Purinone Derivatives as HM74A Agonists |
| 02/09/2012 | US20120035170 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 02/09/2012 | US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides |
| 02/09/2012 | US20120035164 Chemical compounds |
| 02/09/2012 | US20120035163 Novel fused ring compound and use thereof |